Electrochemical immunoassay on expression of integrin Β1 on tumor cells and drug-resistant tumor cells

Biosensors and Bioelectronics

Volumn 38, Issue 1, 2012, Pages 389-395

  Zhou, Bei ^a   Xiao, Xiuli ^a   Xu, Lili ^a   Zhu, Lian ^a   Tan, Liang ^a   Tang, Hao ^a   Zhang, Youyu ^a   Xie, Qingji ^a   Yao, Shouzhuo ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Drug resistance; Electrochemical immunoassay; Enzyme electrode; Integrin 1; Tumor cells

Indexed keywords

ADHESION ABILITY; AMPEROMETRIC RESPONSE; CELL CONCENTRATIONS; CELL NUMBER; COMPETITIVE IMMUNOASSAY; CURRENT CHANGE; DETECTION LIMITS; DRUG RESISTANCE; ELECTROCHEMICAL IMMUNOASSAYS; ELECTRODE SURFACES; GOLD NANOPARTICLES; HORSERADISH PEROXIDASE; HUMAN BREAST CANCER; INTEGRINS; MCF-7 CELLS; MODIFIED GLASSY CARBON ELECTRODE; OPTIMAL CONDITIONS; TUMOR CELLS;

CELL MEMBRANES; DISEASES; ELECTRODES; ENZYME ELECTRODES; GLASS MEMBRANE ELECTRODES; IMMUNOLOGY; KETONES; MONOCLONAL ANTIBODIES; PHENOLS; SANDWICH STRUCTURES; TUMORS;

PHARMACODYNAMICS;

BETA1 INTEGRIN; CD29 MONOCLONAL ANTIBODY; DOXORUBICIN; GOLD NANOPARTICLE; HORSERADISH PEROXIDASE; MONOCLONAL ANTIBODY; NANOCOMPOSITE; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING CELL; ARTICLE; BREAST CANCER; CELL ADHESION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL PULSE VOLTAMMETRY; ELECTROCHEMICAL ANALYSIS; ELECTROCHEMICAL INDIRECT COMPETITIVE IMMUNOASSAY; ELECTROIMMUNOASSAY; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMPEDANCE; LIMIT OF DETECTION; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; TUMOR CELL; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD29; BREAST; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ELECTROCHEMICAL TECHNIQUES; FEMALE; HUMANS; IMMUNOASSAY; LIMIT OF DETECTION; MCF-7 CELLS; MICE;

ARMORACIA RUSTICANA;

EID: 84864382421     PISSN: 09565663     EISSN: 18734235     Source Type: Journal    
DOI: 10.1016/j.bios.2012.06.040     Document Type: Article

References (29)

1. Aoudjit F., Vuori K. Oncogene 2001, 20:4995-5004.
2. Bakalova R., Zhelev Z., Ohba H., Baba Y. Journal of the American Chemical Society 2005, 127:9328-9329.
3. Byl J.A.W., Cline S.D., Utsugi T., Kobunai T., Yamada Y., Osheroff N. Biochemistry 2001, 40:712-718.
4. Cheng W., Ding L., Ding S., Yin Y., Ju H. Angewandte Chemie-International Edition 2009, 48:6465-6468.
5. Damiano J.S., Cress A.E., Hazlehurst L.A., Shtil A.A., Dalton W.S. Blood 1999, 93:1658-1667.
6. Damiano J.S., Hazlehurst L.A., Dalton W.S. Leukemia 2001, 15:1232-1239.
7. Ding L., Ji Q., Qian R., Cheng W., Ju H. Analytical Chemistry 2010, 82:1292-1298.
8. Du D., Ju H., Zhang X., Chen J., Cai J., Chen H. Biochemistry 2005, 44:11539-11545.
9. Esumi K., Sarashina S., Yoshimura T. Langmuir 2004, 20:5189-5191.
10. Frens G. Nature 1973, 241:20-22.
11. Goldfarb A.R., Saidel L.J., Mosovich E. Journal of Biological Chemistry 1951, 193:397-404.
12. Ha J.-H., Won E.-Y., Shin J.-S., Jang M., Ryu K.-S., Bae K.-H., Park S.G., Park B.C., Yoon H.S., Chi S.-W. Journal of the American Chemical Society 2011, 133:1244-1247.
13. Hall M.D., Handley M.D., Gottesman M.M. Trends in Pharmacological Sciences 2009, 30:546-556.
14. Haves J.D., Pulford D.J. Biochemistry 1995, 30:445-600.
15. Hazlehurst L.A., Damiano J.S., Buyuksal I., Pledger W.J., Dalton W.S. Oncogene 2000, 19:4319-4327.
16. Humphries M.J. Biochemical Society Transactions 2000, 28:311-339.
17. Hynes R.O. Cell 1992, 69:11-25.
18. Jiménez-Marín A., Moreno A., Mulas J.M, de la, Millán Y., Morera L., Barbancho M., Llanes D., Garrido J.J. Veterinary Immunology and Immunopathology 2005, 104:281-288.
19. Lee J.J., Jabara H.H., Garibyan L., Rauter I., Sannikova T., Dillon S.R., Bram R., Geha R.S. Journal of Allergy and Clinical Immunology 2010, 126:1234-1241. e2.
20. Li X., Zhen D., Lu X., Xu H., Shao Y., Xue Q., Hu Y., Li B., Sun W. European Journal of Pharmaceutics and Biopharmaceutics 2010, 75:334-340.
21. Liang Z., Wu H., Xia J., Li Y., Zhang Y., Huang K., Wagar N., Yoon Y., Cho H.T., Scala S., Shim H. Biochemical Pharmacology 2010, 79:817-824.
22. Muller C., Bailly J.D., Goubin F., Laredo J., Jaffrezou J.P., Bordier C., Laurent G. International Journal of Cancer 1994, 56:749-754.
23. Persidis A. Nature Biotechnology 1999, 17:94-95.
24. Petruzzelli L., Takami M., Humes H.D. American Journal of Medicine 1999, 106:467-476.
25. Rawal S., Yip S.S.M., Coulombe R.A. Chemical Research in Toxicology 2010, 23:1322-1329.
26. Rouby S.el, Thomas A., Costin D., Rosenberg C.R., Potmesil M., Silber R., Newcomb E.W. Blood 1993, 82:3452-3459.
27. Sethi T., Rintoul R.C., Moore S.M., MacKinnon A.C., Salter D., Choo C., Chilvers E.R., Dransfield I., Donnelly S.C., Strieter R., Haslett C. Nature Medicine 1999, 5:662-668.
28. Sugawara I., Akiyama S., Scheper R.J., Itoyama S. Cancer Letters 1997, 112:23-31.
29. Wang P., Young A., Lo J.B., Song J.H., Lai R., Kneteman N.M., Hao C.-H., Li L. Journal of Proteome Research 2009, 8:3403-3414.